Category Archives: Chemistry
Update your bookmarks and RSS feeds Come to our new home at CENtral Science: cenblog.org/terra-sigillata Well, as I’ve been alluding to, I’ve decided to leave this state of indie blog purgatory and join CENtral Science, the blog platform of the American Chemical Society’s Chemical and Engineering News. C&EN is a weekly publication of the American […]
Bora Zivkovic, DrugMonkey, and I have been really impressed by this idea by the online folks over at the American Chemical Society’s Chemical & Engineering News. This week, their blog network, CENtral Science, has been promoting their presence at the upcoming national ACS meeting in Boston. Folks may not know this but ACS is the […]
Warning: rare self-indulgent post. Blogging has been and will be light over the next few days while we are packing up things around here to move to our next, more permanent home. In the meantime, you may have noticed here and on Twitter that part of my big news is that I will begin writing […]
I’m really excited to be going up to Boston for a few days next week to attend the fall meeting of the American Chemical Society. Besides presenting some of our collaborative work, the highlight of my time there will be with Carmen Drahl of C&EN and The Haystack blog hosting a panel on chemistry and […]
Welcome to readers arriving via Adam Brown’s referral from Cracked.com. I’ve since moved my blog where I have written extensively on the fake weed phenomenon over the last year-and-a-half. Click here to read my compilation of synthetic marijuana posts at the new home of this blog. From the overnight e-mail referrals of PharmGirl, […]
USA Today’s Donna Leinwand spoke yesterday of proposed K2 Spice bans across the US. But a careful analysis of our traffic raises questions as to whether the US military is about to make a move in this regard.
It is rare for a scientist to discover one drug that makes it to market. Sir James not only led the discovery of two major drugs, propranolol and cimetidine. As if that were not enough, each drug was a “first-in-class” agent, the first approved drug that acts via a novel mechanism of action.
A follow-on discussion of Pfizer’s rejected patent claim and some molecular modeling thanks to valued readers, daedalus4u and Prof Ian Musgrave, respectively. You know, science blogging is cool.
“No one wanted to believe it because they didn’t do it first”
Yes, friends: this year’s Nobel Prize in Chemistry would not have been possible without the awesome power of natural products and the contributions of my natural products chemistry colleagues who provided Ramikrishnan, Steitz, and Yonath with the chemical tools for their work. “The ribosome is the target for about 50% of all antibacterial drugs to date, and the advent of high resolution structures of both ribosomal subunits has opened a large number of possibilities for [structure-based drug design] of new and effective drugs in the race against resistance development among bacterial pathogens.”